lifestyle.californiaconsumerbanking.com

Author: XVIVO Perfusion AB

Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO’s Heart Technology

May 18, 2026
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)

May 7, 2026
Interim Report January – March 2026

May 7, 2026
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation

May 7, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto

May 7, 2026
Conference Call on Interim Report January-March 2026

May 6, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal

May 6, 2026
Annual Report 2025

May 4, 2026
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)

May 2, 2026
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members

March 11, 2026